Intended for healthcare professionals

News Roundup [abridged Versions Appear In The Paper Journal]

Regulator restricts use of SSRIs in children

BMJ 2005; 330 doi: (Published 28 April 2005) Cite this as: BMJ 2005;330:984

This article has a correction. Please see:

  1. Lynn Eaton
  1. London

    The European Medicines Agency has ruled that selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) should not be prescribed for children and adolescents under the age of 18, except for limited, approved uses. Some of the drugs have been approved for obsessive compulsive disorder, and one of them has been approved for attention deficit/hyperactivity disorder.

    It is also recommending that strong warnings should be issued throughout the European Union about the potential risk of suicidal behaviour and aggression in these age groups.

    The advice …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription